Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.
作者信息
Zauderer Marjorie G, Krug Lee M
机构信息
Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA.
出版信息
Ann Cardiothorac Surg. 2012 Nov;1(4):487-90. doi: 10.3978/j.issn.2225-319X.2012.10.08.
Abstract
摘要
相似文献
1
Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.胸膜切除术/剥脱术、化疗及调强放射治疗用于恶性胸膜间皮瘤：纳入保留肺手术的多模式治疗原理
Ann Cardiothorac Surg. 2012 Nov;1(4):487-90. doi: 10.3978/j.issn.2225-319X.2012.10.08.
2
High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.胸膜间皮瘤治疗中胸膜剥脱术/去皮质术或活检后进行高剂量照射。
Cancer Radiother. 2017 Dec;21(8):766-773. doi: 10.1016/j.canrad.2017.05.007. Epub 2017 Nov 11.
3
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.半胸强度调制胸膜放射治疗（IMPRINT）作为恶性胸膜间皮瘤患者肺保留多模式治疗一部分的II期研究
J Clin Oncol. 2016 Aug 10;34(23):2761-8. doi: 10.1200/JCO.2016.67.2675. Epub 2016 Jun 20.
4
Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.恶性胸膜间皮瘤肺保存手术后的根治性放疗：生存、失败模式和预后因素。
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):606-13. doi: 10.1016/j.ijrobp.2015.06.029. Epub 2015 Jun 20.
5
Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.恶性胸膜间皮瘤手术后返回预期的肿瘤治疗。
J Thorac Cardiovasc Surg. 2019 Sep;158(3):924-929. doi: 10.1016/j.jtcvs.2019.02.129. Epub 2019 Apr 16.
6
Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.肺减容胸膜切除术治疗恶性胸膜间皮瘤的调强放疗的疾病相关结局和毒性：系统评价。
Pract Radiat Oncol. 2020 Nov-Dec;10(6):423-433. doi: 10.1016/j.prro.2020.02.007. Epub 2020 Feb 20.
7
Extended pleurectomy decortication for the treatment of malignant pleural mesothelioma.扩大胸膜剥脱术治疗恶性胸膜间皮瘤
Multimed Man Cardiothorac Surg. 2019 Nov 5;2019. doi: 10.1510/mmcts.2019.023.
8
Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.现代保肺三联疗法治疗恶性胸膜间皮瘤患者的疗效改善
J Thorac Oncol. 2017 Jun;12(6):993-1000. doi: 10.1016/j.jtho.2017.02.026. Epub 2017 Mar 21.
9
Non-incisional pleurectomy/decortication for malignant pleural mesothelioma.非切口性胸膜切除术/剥脱术治疗恶性胸膜间皮瘤。
Gen Thorac Cardiovasc Surg. 2021 Sep;69(9):1320-1325. doi: 10.1007/s11748-021-01643-z. Epub 2021 May 24.
10
Non-incisional pleurectomy-decortication for malignant pleural mesothelioma.非切开式胸膜切除术-纤维板剥脱术治疗恶性胸膜间皮瘤
Surg Today. 2018 Jun;48(6):656-658. doi: 10.1007/s00595-018-1624-0. Epub 2018 Feb 28.
引用本文的文献
1
Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma.有人喜欢热疗：胸腔内热化疗在胸膜间皮瘤多模式治疗中的潜在作用。
Transl Lung Cancer Res. 2023 Feb 28;12(2):187-189. doi: 10.21037/tlcr-23-46. Epub 2023 Feb 9.
2
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.寻找与间皮瘤中程序性死亡受体配体1（PD-L1）阻断联合使用的有趣伙伴：聚焦于T细胞免疫球蛋白和粘蛋白结构域分子3（TIM-3）和淋巴细胞激活基因3（LAG-3）。
Cancers (Basel). 2021 Jan 14;13(2):282. doi: 10.3390/cancers13020282.
3
Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.完整肺接受放射治疗的恶性胸膜间皮瘤患者的肺毒性的剂量学相关性。
Pract Radiat Oncol. 2019 May;9(3):e331-e337. doi: 10.1016/j.prro.2018.12.008. Epub 2019 Jan 15.
4
Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models.体内和体外模型表明，降低人类恶性胸膜间皮瘤组织中的雌二醇水平可能会抑制肿瘤生长。
Oncotarget. 2016 Jul 26;7(30):47116-47126. doi: 10.18632/oncotarget.9964.
5
Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.恶性胸膜间皮瘤半胸部胸膜调强放疗后的失败模式。
Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):394-401. doi: 10.1016/j.ijrobp.2014.05.032. Epub 2014 Jul 26.
本文引用的文献
1
Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.胸膜调强放疗治疗恶性胸膜间皮瘤。
Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1278-83. doi: 10.1016/j.ijrobp.2011.09.027. Epub 2012 May 18.
2
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.恶性胸膜间皮瘤的三联疗法：来自 EORTC 二期多中心试验的结果。
Eur Respir J. 2010 Dec;36(6):1362-9. doi: 10.1183/09031936.00039510. Epub 2010 Jun 4.
3
Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma.恶性胸膜间皮瘤三联疗法后的生存及复发模式
Gen Thorac Cardiovasc Surg. 2009 Nov;57(11):585-90. doi: 10.1007/s11748-009-0440-2. Epub 2009 Nov 12.
4
Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.恶性胸膜间皮瘤三联疗法后的生存情况：根治性胸膜切除术、顺铂/培美曲塞化疗和放疗。
Lung Cancer. 2011 Jan;71(1):75-81. doi: 10.1016/j.lungcan.2009.08.019. Epub 2009 Sep 17.
5
Trimodality therapy for malignant pleural mesothelioma.恶性胸膜间皮瘤的三联疗法
Ann Thorac Surg. 2009 Sep;88(3):870-5; discussion 876. doi: 10.1016/j.athoracsur.2009.05.036.
6
Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.西澳大利亚州接受三联疗法的恶性胸膜间皮瘤患者的治疗结果。
J Thorac Oncol. 2009 Aug;4(8):1010-6. doi: 10.1097/JTO.0b013e3181ae25bf.
7
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.培美曲塞联合顺铂新辅助治疗后行胸膜外全肺切除术及放疗用于恶性胸膜间皮瘤的多中心II期试验
J Clin Oncol. 2009 Jun 20;27(18):3007-13. doi: 10.1200/JCO.2008.20.3943. Epub 2009 Apr 13.
8
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.对于恶性胸膜间皮瘤，采用诱导化疗后行胸膜外全肺切除术及辅助大剂量半胸放疗的三联疗法。
J Clin Oncol. 2009 Mar 20;27(9):1413-8. doi: 10.1200/JCO.2008.17.5604. Epub 2009 Feb 17.
9
Trimodality treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤的三联疗法
J Thorac Oncol. 2008 May;3(5):499-504. doi: 10.1097/JTO.0b013e31816fca1b.
10
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.胸膜外肺切除术与胸膜剥脱术/纤维板剥脱术治疗恶性胸膜间皮瘤的手术疗效：663例患者的结果
J Thorac Cardiovasc Surg. 2008 Mar;135(3):620-6, 626.e1-3. doi: 10.1016/j.jtcvs.2007.10.054. Epub 2008 Feb 14.
Zotero 插件